Literature DB >> 17668949

The impact of protons on the incidence of second malignancies in radiotherapy.

Eric J Hall1.   

Abstract

Protons represent a logical step forward as a modality for radiotherapy because it is possible to concentrate dose in the tumor region and minimize dose to normal tissue. The pencil beam emerging from a cyclotron or synchrotron needs to be expanded to a larger size to cover tumors of realistic size. Ideally, this should be accomplished by scanning the pencil beam using magnetic fields, but this is technically challenging. The simpler method is to use passive modulation, the downside of which is that neutrons are produced in the scattering foil, which results in a total body dose to the patient. Neutrons are highly effective at inducing second cancers and so, for the full potential of protons to be realized, spot scanning is essential.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17668949     DOI: 10.1177/15330346070060S405

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  13 in total

1.  Estimate of the uncertainties in the relative risk of secondary malignant neoplasms following proton therapy and intensity-modulated photon therapy.

Authors:  Jonas D Fontenot; Charles Bloch; David Followill; Uwe Titt; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2010-11-12       Impact factor: 3.609

2.  A TRACK-REPEATING ALGORITHM FOR FAST MONTE CARLO DOSE CALCULATIONS OF PROTON RADIOTHERAPY.

Authors:  Pablo Yepes; Sharmalee Randeniya; Phillip J Taddei; Wayne D Newhauser
Journal:  Nucl Technol       Date:  2009-12-01

3.  Contemporary Proton Therapy Systems Adequately Protect Patients from Exposure to Stray Radiation.

Authors:  Wayne D Newhauser; Jonas D Fontenot; Phillip J Taddei; Dragan Mirkovic; Annelise Giebeler; Rui Zhang; Anita Mahajan; David Kornguth; Marilyn Stovall; Pablo Yepes; Shiao Woo; Radhe Mohan
Journal:  AIP Conf Proc       Date:  2009-03-10

4.  Emerging role of radiation induced bystander effects: Cell communications and carcinogenesis.

Authors:  Rajamanickam Baskar
Journal:  Genome Integr       Date:  2010-09-12

5.  Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer.

Authors:  Jonas D Fontenot; Andrew K Lee; Wayne D Newhauser
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-06-01       Impact factor: 7.038

6.  Lifetime increased cancer risk in mice following exposure to clinical proton beam-generated neutrons.

Authors:  Leo E Gerweck; Peigen Huang; Hsiao-Ming Lu; Harald Paganetti; Yenong Zhou
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-05-01       Impact factor: 7.038

7.  The risk of developing a second cancer after receiving craniospinal proton irradiation.

Authors:  Wayne D Newhauser; Jonas D Fontenot; Anita Mahajan; David Kornguth; Marilyn Stovall; Yuanshui Zheng; Phillip J Taddei; Dragan Mirkovic; Radhe Mohan; James D Cox; Shiao Woo
Journal:  Phys Med Biol       Date:  2009-03-20       Impact factor: 3.609

Review 8.  Minimizing second cancer risk following radiotherapy: current perspectives.

Authors:  John Ng; Igor Shuryak
Journal:  Cancer Manag Res       Date:  2014-12-17       Impact factor: 3.989

9.  Inter-Institutional Comparison of Personalized Risk Assessments for Second Malignant Neoplasms for a 13-Year-Old Girl Receiving Proton versus Photon Craniospinal Irradiation.

Authors:  Phillip J Taddei; Nabil Khater; Rui Zhang; Fady B Geara; Anita Mahajan; Wassim Jalbout; Angélica Pérez-Andújar; Bassem Youssef; Wayne D Newhauser
Journal:  Cancers (Basel)       Date:  2015-03-10       Impact factor: 6.639

Review 10.  Secondary Malignancy Risk Following Proton Radiation Therapy.

Authors:  Bree R Eaton; Shannon M MacDonald; Torunn I Yock; Nancy J Tarbell
Journal:  Front Oncol       Date:  2015-11-26       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.